Table of Contents Author Guidelines Submit a Manuscript
Sarcoma
Volume 2011, Article ID 405437, 15 pages
http://dx.doi.org/10.1155/2011/405437
Review Article

Chondrosarcoma: With Updates on Molecular Genetics

1Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 138-736, Republic of Korea
2Department of Pathology, Weill Medical College of Cornell University, The Methodist Hospital, Houston, TX 77030, USA

Received 14 September 2010; Revised 23 November 2010; Accepted 17 December 2010

Academic Editor: C. Verhoef

Copyright © 2011 Mi-Jung Kim et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [22 citations]

The following is the list of published articles that have cited the current article.

  • Madhuri Gawande, Nisu Swastika, Minal Chaudhary, and Swati Patil, “Chondrosarcoma of maxilla.,” Journal of oral and maxillofacial pathology : JOMFP, vol. 18, no. 3, pp. 423–7, . View at Publisher · View at Google Scholar
  • Ravija Patel, and Bipasha Mukherjee, “Mesenchymal chondrosarcoma of the orbit,” Orbit, vol. 31, no. 2, pp. 126–128, 2012. View at Publisher · View at Google Scholar
  • Satoshi Kawaguchi, Tao Sun, Patrick P. Lin, Michael Deavers, Nusrat Harun, and Valerae O. Lewis, “Does Ifosfamide Therapy Improve Survival of Patients With Dedifferentiated Chondrosarcoma?,” Clinical Orthopaedics and Related Research®, 2013. View at Publisher · View at Google Scholar
  • Labros Goutzanis, Evagelos F. Kalfarentzos, Vassilis Petsinis, and Nick Papadogeorgakis, “Chondrosarcoma of the mandibular condyle in a patient with Werner syndrome: A case report,” Journal of Cranio-Maxillofacial Surgery, 2013. View at Publisher · View at Google Scholar
  • Jesse E. Otero, Jeff W. Stevens, Allison E. Malandra, Douglas C. Fredericks, Paul R. Odgren, Joseph A. Buckwalter, and Jose Morcuende, “Osteoclast inhibition impairs chondrosarcoma growth and bone destruction,” Journal of Orthopaedic Research, 2014. View at Publisher · View at Google Scholar
  • P. Anract, F. Larousserie, O. Mir, and A. Feydy, “Condrosarcomas,” EMC - Aparato Locomotor, vol. 47, no. 1, pp. 1–14, 2014. View at Publisher · View at Google Scholar
  • L. He, Z. Yang, J. Zhou, and W. Wang, “The clinical pathological significance of FRAT1 and ROR2 expression in cartilage tumors,” Clinical & Translational Oncology, vol. 17, no. 6, pp. 438–445, 2015. View at Publisher · View at Google Scholar
  • Franz Liska, Andreas Toepfer, Melanie Straub, Hans Rechl, and Ruediger von Eisenhart-Rothe, “Delayed diagnosis of clear cell chondrosarcoma after total hip replacement. A case report of a rare entity encountered in common surgery,” Hip International, vol. 25, no. 1, pp. 98–100, 2015. View at Publisher · View at Google Scholar
  • Bunyamin Isik, Haci K. Erdemli, Ismail Comertoglu, Sumeyya Akyol, Ridvan Firat, Mehmet Kaya, Omer Akyol, and Kadir Demircan, “Changes of the Expressions of Orphan and gon-ADAMTS in Chondrosarcoma Cells,” Uhod-Uluslararasi Hematoloji-Onkoloji Dergisi, vol. 25, no. 3, pp. 158–165, 2015. View at Publisher · View at Google Scholar
  • Lile He, Zhulin Yang, and Zhihong Li, “The clinical pathological significance of Thy1 and CD49f expression in chondrosarcomas,” Pathology - Research and Practice, 2016. View at Publisher · View at Google Scholar
  • Jingyang Chi, Mingchao Zhang, and Jianmin Kang, “Classical intracranial chondrosarcoma: A case report,” Oncology Letters, vol. 12, no. 5, pp. 4051–4053, 2016. View at Publisher · View at Google Scholar
  • Diana Bell, Franco DeMonte, Shaan M. Raza, Paul W. Gidley, Jeanne M. Meis, and David R. Grosshans, “Multimodality treatment of skull base chondrosarcomas: The role of histology specific treatment protocols,” Clinical Neurosurgery, vol. 81, no. 3, pp. 520–530, 2017. View at Publisher · View at Google Scholar
  • Shaan M Raza, Paul W Gidley, Michael E Kupferman, Ehab Y Hanna, Shirley Y Su, and Franco DeMonte, “Site-Specific Considerations in the Surgical Management of Skull Base Chondrosarcomas,” Operative Neurosurgery, vol. 14, no. 6, pp. 611–619, 2017. View at Publisher · View at Google Scholar
  • Kenneth Samora Rankin, Eleftherios Tsiridis, Craig Gerrand, Anja Krippner-Heidenreich, Kenneth Dalgarno, Ricardo Da Conceicao Ribeiro, Emma Haagensen, Dimitra Papanikolaou, Kapriniotis Konstantinos, and Zakareya Gamie, “TNF-related apoptosis-inducing ligand (TRAIL) for bone sarcoma treatment: pre-clinical and clinical data,” Cancer Letters, 2017. View at Publisher · View at Google Scholar
  • Md. Shahid Alam, Nirmala Subramanian, Akruti Sunil Desai, and S. Krishnakumar, “Mesenchymal chondrosarcoma of the orbit: A case report with 5 years of follow-up,” Orbit, pp. 1–3, 2017. View at Publisher · View at Google Scholar
  • Carla Aparecida Pinheiro, Iberê Cauduro Soares, Rui Manuel Vieira Reis, Sandra Regina Morini da Silva, Marjori Leiva Camparoto, Adhemar Longatto Filho, Valter Penna, Jeremy Squire, Isabela de Carvalho, and Maicon Fernando Zanon da Silva, “Centrosome amplification in chondrosarcomas: A primary cell culture and cryopreserved tumor sample study,” Oncology Letters, vol. 13, no. 3, pp. 1835–1839, 2017. View at Publisher · View at Google Scholar
  • Gautam U. Mehta, Franco DeMonte, Shirley Y. Su, Michael E. Kupferman, Ehab Y. Hanna, and Shaan M. Raza, “Endoscopic endonasal transpterygoid transnasopharyngeal management of petroclival chondrosarcomas without medial extension,” Journal of Neurosurgery, pp. 1–8, 2018. View at Publisher · View at Google Scholar
  • Donia Ghedira, Aurélien Voissière, Caroline Peyrode, Jamil Kraiem, Yvain Gerard, Elise Maubert, Magali Vivier, Elisabeth Miot-Noirault, Jean-Michel Chezal, Farhat Farhat, and Valérie Weber, “Structure-activity relationship study of hypoxia-activated prodrugs for proteoglycan-targeted chemotherapy in chondrosarcoma,” European Journal of Medicinal Chemistry, 2018. View at Publisher · View at Google Scholar
  • Xiao Yang, Guoxing Zhu, Zhengjie Yang, Ke Zeng, Fengxiang Liu, and Junying Sun, “Expression of PD-L1/PD-L2 is associated with high proliferation index of Ki-67 but not with TP53 overexpression in chondrosarcoma,” The International Journal of Biological Markers, pp. 172460081877446, 2018. View at Publisher · View at Google Scholar
  • Marc El Beaino, Jason Roszik, John A. Livingston, Wei-Lien Wang, Alexander J. Lazar, Behrang Amini, Vivek Subbiah, Valerae Lewis, and Anthony P. Conley, “Mesenchymal Chondrosarcoma: a Review with Emphasis on its Fusion-Driven Biology,” Current Oncology Reports, vol. 20, no. 5, 2018. View at Publisher · View at Google Scholar
  • Kinga Szurian, Karl Kashofer, and Bernadette Liegl-Atzwanger, “Role of Next-Generation Sequencing as a Diagnostic Tool for the Evaluation of Bone and Soft-Tissue Tumors,” Pathobiology, vol. 84, no. 6, pp. 323–338, 2018. View at Publisher · View at Google Scholar
  • Nagavalli Somasundaram, Sock Hoai Chan, Richard Quek, and Joanne Ngeow, “Advances in Sarcoma Genomics and Therapeutic Management,” Oncogenomics, pp. 609–621, 2019. View at Publisher · View at Google Scholar